LIGAND PHARMACEUTICALS INCORPORATED: accounts_receivable
| Value | {"amount": 38376000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2024-12-31) |
| Status | current |
| Entity | LIGAND PHARMACEUTICALS INCORPORATED |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:53:38.376979+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/38ebfe39-cc59-46b7-8090-fcd38ffbe206
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000886163-25-000012Retrieved: 2026-08-19T08:53:38.376979+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000886163/accounts-receivable/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/38ebfe39-cc59-46b7-8090-fcd38ffbe206
History
- no predecessors — first report